Wells Fargo Maintains Equal-Weight on LeMaitre Vascular, Lowers Price Target to $94

Wells Fargo analyst Nathan Treybeck maintains LeMaitre Vascular (NASDAQ:LMAT) with a Equal-Weight and lowers the price target from $104 to $94.